持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/04/20 | 8,490 | 8,550 | 8,350 | 8,390 | -50 | -0.6% | 26,800 |
2016/04/19 | 8,390 | 8,480 | 8,380 | 8,440 | +140 | +1.7% | 22,400 |
2016/04/18 | 8,250 | 8,360 | 8,160 | 8,300 | -170 | -2% | 20,000 |
2016/04/15 | 8,370 | 8,510 | 8,350 | 8,470 | +20 | +0.2% | 31,100 |
2016/04/14 | 8,250 | 8,480 | 8,220 | 8,450 | +350 | +4.3% | 39,300 |
2016/04/13 | 8,040 | 8,130 | 7,990 | 8,100 | +40 | +0.5% | 32,300 |
2016/04/12 | 8,170 | 8,250 | 8,050 | 8,060 | -70 | -0.9% | 30,100 |
2016/04/11 | 8,140 | 8,190 | 8,020 | 8,130 | -30 | -0.4% | 21,400 |
2016/04/08 | 7,910 | 8,240 | 7,880 | 8,160 | +150 | +1.9% | 62,700 |
2016/04/07 | 7,750 | 8,060 | 7,750 | 8,010 | +210 | +2.7% | 29,100 |
2016/04/06 | 7,910 | 7,910 | 7,760 | 7,800 | -120 | -1.5% | 50,800 |
2016/04/05 | 7,970 | 8,080 | 7,870 | 7,920 | -140 | -1.7% | 37,800 |
2016/04/04 | 7,970 | 8,200 | 7,930 | 8,060 | +50 | +0.6% | 34,200 |
2016/04/01 | 8,390 | 8,450 | 7,970 | 8,010 | -350 | -4.2% | 65,300 |
2016/03/31 | 8,520 | 8,570 | 8,340 | 8,360 | -80 | -0.9% | 54,000 |
2016/03/30 | 8,470 | 8,570 | 8,360 | 8,440 | -30 | -0.4% | 45,100 |
2016/03/29 | 8,350 | 8,520 | 8,340 | 8,470 | +90 | +1.1% | 44,300 |
2016/03/28 | 8,250 | 8,390 | 8,250 | 8,380 | +220 | +2.7% | 42,000 |
2016/03/25 | 8,280 | 8,300 | 8,140 | 8,160 | -20 | -0.2% | 33,800 |
2016/03/24 | 8,240 | 8,270 | 8,120 | 8,180 | +50 | +0.6% | 50,700 |
2016/03/23 | 8,170 | 8,280 | 8,070 | 8,130 | +70 | +0.9% | 33,800 |
2016/03/22 | 7,930 | 8,140 | 7,930 | 8,060 | +240 | +3.1% | 45,800 |
2016/03/18 | 7,950 | 7,960 | 7,770 | 7,820 | -230 | -2.9% | 53,500 |
2016/03/17 | 8,120 | 8,180 | 8,020 | 8,050 | -50 | -0.6% | 36,100 |
2016/03/16 | 8,090 | 8,180 | 8,050 | 8,100 | -30 | -0.4% | 29,700 |
2016/03/15 | 8,070 | 8,240 | 8,050 | 8,130 | -10 | -0.1% | 37,500 |
2016/03/14 | 8,180 | 8,290 | 8,100 | 8,140 | -10 | -0.1% | 32,100 |
2016/03/11 | 8,080 | 8,230 | 8,000 | 8,150 | +40 | +0.5% | 53,700 |
2016/03/10 | 8,140 | 8,210 | 8,060 | 8,110 | ±0 | ±0% | 36,500 |
2016/03/09 | 8,120 | 8,140 | 8,000 | 8,110 | +30 | +0.4% | 46,200 |
2016/03/08 | 8,220 | 8,320 | 8,060 | 8,080 | -250 | -3% | 50,300 |
2016/03/07 | 8,380 | 8,440 | 8,210 | 8,330 | -50 | -0.6% | 41,000 |
2016/03/04 | 8,510 | 8,510 | 8,290 | 8,380 | -190 | -2.2% | 45,900 |
2016/03/03 | 8,530 | 8,580 | 8,440 | 8,570 | ±0 | ±0% | 46,200 |
2016/03/02 | 8,600 | 8,670 | 8,450 | 8,570 | +100 | +1.2% | 49,600 |
2016/03/01 | 8,560 | 8,560 | 8,410 | 8,470 | -20 | -0.2% | 43,100 |
2016/02/29 | 8,570 | 8,680 | 8,470 | 8,490 | -80 | -0.9% | 50,300 |
2016/02/26 | 8,660 | 8,700 | 8,530 | 8,570 | -90 | -1% | 44,500 |
2016/02/25 | 8,510 | 8,720 | 8,510 | 8,660 | +150 | +1.8% | 41,000 |
2016/02/24 | 8,420 | 8,700 | 8,400 | 8,510 | +90 | +1.1% | 51,100 |
2016/02/23 | 8,560 | 8,670 | 8,390 | 8,420 | -120 | -1.4% | 34,700 |
2016/02/22 | 8,470 | 8,560 | 8,460 | 8,540 | +70 | +0.8% | 59,600 |
2016/02/19 | 8,400 | 8,550 | 8,350 | 8,470 | -40 | -0.5% | 37,600 |
2016/02/18 | 8,670 | 8,690 | 8,460 | 8,510 | +20 | +0.2% | 81,100 |
2016/02/17 | 8,750 | 8,750 | 8,380 | 8,490 | -170 | -2% | 60,900 |
2016/02/16 | 8,830 | 8,960 | 8,660 | 8,660 | -350 | -3.9% | 62,500 |
2016/02/15 | 8,930 | 9,090 | 8,680 | 9,010 | +660 | +7.9% | 63,900 |
2016/02/12 | 8,510 | 8,650 | 8,280 | 8,350 | -430 | -4.9% | 84,200 |
2016/02/10 | 9,220 | 9,280 | 8,670 | 8,780 | -440 | -4.8% | 95,300 |
2016/02/09 | 9,330 | 9,420 | 9,210 | 9,220 | -510 | -5.2% | 79,300 |
2101~
2150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム